TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.18) by 11.11 percent. This is a 9.09 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $19.291 million which missed the analyst consensus estimate of $20.008 million by 3.59 percent. This is a 4.49 percent decrease over sales of $20.197 million the same period last year.